OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 123 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 1.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $126,000 | -61.3% | 223,269 | +17.7% | 0.00% | -100.0% |
| Q4 2015 | $326,000 | -17.0% | 189,650 | +1.8% | 0.00% | 0.0% |
| Q3 2015 | $393,000 | -57.5% | 186,278 | -0.3% | 0.00% | -50.0% |
| Q2 2015 | $925,000 | -47.3% | 186,878 | -16.6% | 0.00% | -50.0% |
| Q1 2015 | $1,755,000 | +27.4% | 224,131 | -1.5% | 0.00% | +33.3% |
| Q4 2014 | $1,378,000 | +42.8% | 227,431 | +0.4% | 0.00% | +50.0% |
| Q3 2014 | $965,000 | -26.4% | 226,464 | +6.6% | 0.00% | -33.3% |
| Q2 2014 | $1,312,000 | -0.5% | 212,345 | +4.6% | 0.00% | 0.0% |
| Q1 2014 | $1,319,000 | +27.7% | 202,945 | +10.6% | 0.00% | 0.0% |
| Q4 2013 | $1,033,000 | -1.2% | 183,545 | +7.7% | 0.00% | 0.0% |
| Q3 2013 | $1,046,000 | +8.4% | 170,345 | +3.3% | 0.00% | 0.0% |
| Q2 2013 | $965,000 | +7.8% | 164,921 | +15.1% | 0.00% | 0.0% |
| Q1 2013 | $895,000 | – | 143,249 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,250,000 | $7,725,000 | 6.48% |
| Ghost Tree Capital, LLC | 250,000 | $1,545,000 | 1.09% |
| Rock Springs Capital Management LP | 905,000 | $5,593,000 | 1.00% |
| Palo Alto Investors LP | 1,931,324 | $11,936,000 | 0.89% |
| PFM Health Sciences, LP | 4,604,958 | $28,459,000 | 0.57% |
| NEA Management Company, LLC | 1,935,300 | $11,960,000 | 0.56% |
| Rhenman & Partners Asset Management AB | 300,199 | $1,855,000 | 0.55% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 1,752,792 | $10,832,000 | 0.50% |
| CQS Cayman LP | 660,040 | $4,079,000 | 0.25% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,684,300 | $16,589,000 | 0.24% |